FIELD: pharmacy.
SUBSTANCE: invention refers to a hyaluronic acid binding synthetic peptidoglycan, which contains a synthetic peptide conjugated to chondroitin sulfate, wherein the synthetic peptide comprises an amino acid sequence having at least 80% identity of GAHWQFNALTVRGG sequence. Pharmaceutical composition comprising synthetic peptidoglycan, and an arthritis treatment method are also proposed.
EFFECT: increased efficiency of treatment.
22 cl, 26 dwg, 3 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RESORBABLE EXTRACELLULAR MATRIX CONTAINING COLLAGEN I AND COLLAGEN II FOR RESTRUCTURING CARTILAGE | 2002 |
|
RU2323011C2 |
| USE OF OPTIONS OF NATRIURETIC PEPTIDE OF TYPE C FOR TREATMENT OF OSTEOARTHRITIS | 2016 |
|
RU2759679C2 |
| NEW PEPTIDE AND ITS APPLICATION | 2011 |
|
RU2525913C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF PERIODONTOSIS OR TRAUMATIC TOOTH DISLOCATION | 2021 |
|
RU2811919C1 |
| VERSIONS OF C-TYPE NATRIURETIC PEPTIDE | 2010 |
|
RU2573911C2 |
| TISSUE STRUCTURES OBTAINED BY BIOENGINEERING, AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2011 |
|
RU2645473C2 |
| IN-SITU SYSTEM FOR INTRA-ARTICULAR REGENERATION OF CARTILAGINOUS AND BONE TISSUES | 2007 |
|
RU2451527C2 |
| CHONDROITIN FOR APPLICATION IN MEDICINE | 2013 |
|
RU2642964C2 |
| COMPOSITIONS SUITABLE TO TREAT DERMAL SIGNS OF AGING | 2005 |
|
RU2409290C2 |
| BIOLOGICALLY ACTIVE ADDITIVE FROM MARINE HYDROBIONTS - SOURCE OF HONDROITINSULFATE AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2623738C1 |
